Poseida Therapeutics, Inc. (PSTX) Financials

PSTX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 273.9 million 170.2 million
2023-09-30 302.3 million 178.6 million
2023-06-30 281.2 million 145.9 million
2023-03-31 313.6 million 156.1 million

PSTX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -29.1 million 5.1 million
2023-09-30 7.1 million 5.1 million
2023-06-30 -34.5 million 5.5 million
2023-03-31 -38.8 million 7.5 million

PSTX Net Income

No data available :(

PSTX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 212.2 million - 26.8 million
2023-09-30 238.8 million - 27.8 million
2023-06-30 214.6 million 58.4 million 28.7 million
2023-03-31 247.2 million 58.3 million 29.6 million

PSTX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 90.2 million
2023-09-30 91.9 million
2023-06-30 86.8 million
2023-03-31 86.3 million

PSTX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 309000 42.0 million 8.9 million -
2023-09-30 789000 37.5 million 8.1 million -
2023-06-30 1.2 million 39.2 million 8.7 million -
2023-03-31 784000 38.1 million 11.8 million -

PSTX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 25.0 million 4.2 million
2023-09-30 9.4 million 1.4 million
2023-06-30 20.0 million 1.4 million
2023-03-31 10.3 million 1.3 million

PSTX

Price: $2.79

52 week price:
1.54
4.27

Earnings Per Share: -1.37 USD

P/E Ratio: -2.27

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 268000

Market Capitalization: 262.4 million

Links: